FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2753057159> ?p ?o ?g. }

• W2753057159 endingPage "4672" @default.
• W2753057159 startingPage "4664" @default.
• W2753057159 abstract "Neuroblastoma is an aggressive and drug-resistant refractory cancer. The human high-risk neuroblastoma cell line, SK-N-AS (non-amplified N-myc) is derived from stromal cells and it is resistant to treatment with retinoic acid (1, RA), which is a chemotherapeutic agent used to induce neuronal cellular differentiation of neuroblastomas. We have developed p-dodecylaminophenol (3, p-DDAP), based on N-(4-hydroxyphenyl)retinamide (2, 4-HPR), a synthetic amide of 1, since 1 and 2 are associated with the side-effect of nyctalopia. In order to evaluate the effects of 3 on high-risk neuroblastomas, we employed SK-N-AS cells as well asa second high-risk human neuroblastoma cell line, IMR-32, which is derived from neuronal cells (amplified N-myc, drug sensitive). Compound 3 suppressed cell growth of SK-N-AS and IMR-32 cells more effectively than 1, 2, p-decylaminophenol (4, p-DAP), N-(4-hydroxyphenyl)dodecananamide (5, 4-HPDD) or N-(4-hydroxyphenyl)decananamide (6, 4-HPD). In SK-N-AS cells, 3 induced G0/G1 arrest and apoptosis to a greater extent than 1 and 2. In IMR-32 cells, 3 induced apoptosis to a similar extent as 1 and 2, potentially by inhibiting N-myc expression. In addition, i.p. administration of 3 suppressed tumor growth in SK-N-AS-implanted mice in vivo. Since 3 showed no effects on blood retinol concentrations, in contrast to reductions following the administration of 2, it exhibited excellent anticancer efficacy against high-risk neuroblastoma SK-N-AS and IMR-32 expressing distinct levels of N-myc. Compound 3 may have potential for clinical use in the treatment of refractory neuroblastoma with reduced side effects." @default.
• W2753057159 created "2017-09-15" @default.
• W2753057159 creator A5035038653 @default.
• W2753057159 creator A5041858131 @default.
• W2753057159 creator A5065898451 @default.
• W2753057159 creator A5072628472 @default.
• W2753057159 creator A5076993537 @default.
• W2753057159 date "2017-10-01" @default.
• W2753057159 modified "2023-09-27" @default.
• W2753057159 title "Anticancer efficacy of p-dodecylaminophenol against high-risk and refractory neuroblastoma cells in vitro and in vivo" @default.
• W2753057159 cites W1948079440 @default.
• W2753057159 cites W1963658186 @default.
• W2753057159 cites W1965254413 @default.
• W2753057159 cites W1969315337 @default.
• W2753057159 cites W1996261345 @default.
• W2753057159 cites W1999180631 @default.
• W2753057159 cites W2008021517 @default.
• W2753057159 cites W2011702035 @default.
• W2753057159 cites W2020843986 @default.
• W2753057159 cites W2043211160 @default.
• W2753057159 cites W2056715721 @default.
• W2753057159 cites W2056968477 @default.
• W2753057159 cites W2064921414 @default.
• W2753057159 cites W2066166009 @default.
• W2753057159 cites W2067630917 @default.
• W2753057159 cites W2068740421 @default.
• W2753057159 cites W2070755926 @default.
• W2753057159 cites W2078610083 @default.
• W2753057159 cites W2093947533 @default.
• W2753057159 cites W2096398040 @default.
• W2753057159 cites W2098282574 @default.
• W2753057159 cites W2098860085 @default.
• W2753057159 cites W2101744160 @default.
• W2753057159 cites W2103146199 @default.
• W2753057159 cites W2111733282 @default.
• W2753057159 cites W2112738731 @default.
• W2753057159 cites W2130925781 @default.
• W2753057159 cites W2132855064 @default.
• W2753057159 cites W2158847914 @default.
• W2753057159 cites W2167599338 @default.
• W2753057159 cites W2171322600 @default.
• W2753057159 cites W2172027841 @default.
• W2753057159 cites W2327522594 @default.
• W2753057159 cites W2522170908 @default.
• W2753057159 cites W625441648 @default.
• W2753057159 doi "https://doi.org/10.1016/j.bmcl.2017.09.005" @default.
• W2753057159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28927789" @default.
• W2753057159 hasPublicationYear "2017" @default.
• W2753057159 type Work @default.
• W2753057159 sameAs 2753057159 @default.
• W2753057159 citedByCount "6" @default.
• W2753057159 countsByYear W27530571592018 @default.
• W2753057159 countsByYear W27530571592019 @default.
• W2753057159 countsByYear W27530571592022 @default.
• W2753057159 countsByYear W27530571592023 @default.
• W2753057159 crossrefType "journal-article" @default.
• W2753057159 hasAuthorship W2753057159A5035038653 @default.
• W2753057159 hasAuthorship W2753057159A5041858131 @default.
• W2753057159 hasAuthorship W2753057159A5065898451 @default.
• W2753057159 hasAuthorship W2753057159A5072628472 @default.
• W2753057159 hasAuthorship W2753057159A5076993537 @default.
• W2753057159 hasConcept C150903083 @default.
• W2753057159 hasConcept C153911025 @default.
• W2753057159 hasConcept C16930146 @default.
• W2753057159 hasConcept C185592680 @default.
• W2753057159 hasConcept C190283241 @default.
• W2753057159 hasConcept C202751555 @default.
• W2753057159 hasConcept C207001950 @default.
• W2753057159 hasConcept C2776715637 @default.
• W2753057159 hasConcept C2781121885 @default.
• W2753057159 hasConcept C31573885 @default.
• W2753057159 hasConcept C502942594 @default.
• W2753057159 hasConcept C54355233 @default.
• W2753057159 hasConcept C55493867 @default.
• W2753057159 hasConcept C62112901 @default.
• W2753057159 hasConcept C81885089 @default.
• W2753057159 hasConcept C86803240 @default.
• W2753057159 hasConcept C98274493 @default.
• W2753057159 hasConceptScore W2753057159C150903083 @default.
• W2753057159 hasConceptScore W2753057159C153911025 @default.
• W2753057159 hasConceptScore W2753057159C16930146 @default.
• W2753057159 hasConceptScore W2753057159C185592680 @default.
• W2753057159 hasConceptScore W2753057159C190283241 @default.
• W2753057159 hasConceptScore W2753057159C202751555 @default.
• W2753057159 hasConceptScore W2753057159C207001950 @default.
• W2753057159 hasConceptScore W2753057159C2776715637 @default.
• W2753057159 hasConceptScore W2753057159C2781121885 @default.
• W2753057159 hasConceptScore W2753057159C31573885 @default.
• W2753057159 hasConceptScore W2753057159C502942594 @default.
• W2753057159 hasConceptScore W2753057159C54355233 @default.
• W2753057159 hasConceptScore W2753057159C55493867 @default.
• W2753057159 hasConceptScore W2753057159C62112901 @default.
• W2753057159 hasConceptScore W2753057159C81885089 @default.
• W2753057159 hasConceptScore W2753057159C86803240 @default.
• W2753057159 hasConceptScore W2753057159C98274493 @default.
• W2753057159 hasFunder F4320320912 @default.
• W2753057159 hasFunder F4320323514 @default.
• W2753057159 hasFunder F4320334764 @default.

• next